22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/06/21 | 8-K | Current report filing |
|
   |
30 |
| 05/04/21 | 8-K | Current report filing |
|
|
4 |
| 05/03/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/05/21 | DEF 14A | Definitive proxy statements |
|
58 | |
| 04/01/21 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/01/21 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/31/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
